Peripheral myelin protein 22 (PMP22) is a 22-kDa glycoprotein mainly expressed by Schwann cells (SCs
INTRODUCTION
Peripheral myelin protein 22 (PMP22) is a small hydrophobic molecule originally identified as a protein involved in peripheral nerve regeneration and cell cycle control (for review Naef & Suter, 1998) . Alterations in PMP22 expression are associated with heritable peripheral neuropathies in human, mouse, and rat (Suter & Snipes, 1995) . In the majority of PMP22-associated peripheral neuropathies, characterized as Charcot-Marie-Tooth disease type 1A (CMT1A), a 1.5-Mb region on chromosome 17, including the PMP22 gene, is duplicated (Matsunami et al., 1992) . In another group of peripheral neuropathies, Hereditary Neuropathy with liability to Pressure Palsies (HNPP), the analogous region on chromosome 17 is deleted (Chance et al., 1993 (Chance et al., , 1994 . Quantitative ultrastuctural immunocytochemical analyses of CMT1A and HNPP patients have revealed elevated or reduced expression of PMP22, respectively, compared to controls (Vallat et al., 1996) . A role for PMP22 in the pathogenesis in CMT1A and HNPP has been substantiated by genetically engineered animal models (reviewed in Notterpek & Tolwani, 1999) . These results indicate that correct PMP22 expression levels are essential for normal peripheral nerve biology.
Another mechanism by which PMP22 can lead to nerve pathology is by single point mutations (Naef & Suter, 1998) . To date, approximately 20 different mutations in PMP22 have been identified, the majority of which are found in transmembrane domains (Naef & Suter, 1998) . A number of these mutations impair the normal intracellular trafficking of the protein with the mutated PMP22 remaining inside the cell (Naef & Suter, 1999; Tobler et al., 1999) . In one particular PMP22 mutation, that in the Trembler-J mouse, the mutant PMP22 accumulates in the intermediate compartment of cultured SCs and, because PMP22 dimerizes, some of the wild-type protein forms a heterodimer with the
